Abstract:Several drugs of aziridinylbenzoquinone analogs have undergone clinical trials as potential antitumor drugs. These bioreductive compounds are designed to kill tumor cells preferentially within the hypoxic microenvironment. From our previous reported data, it was round that the synthesized 2-aziridin-1-yl-3-[(2-{2-[(3-aziridin-1,4-dioxo-1,4-dihydronaphthalen-2-yl)thio]ethoxy}ethyl)thio]naphthoquinone (AZ-1) is a bioreductive compound with potent lethal effect on oral cancer cell, OEC-M1. It was found in this study that the lethal effect of the oral cancer cell lines OEC-M1 induced by AZ-1 wits mediated through the cell cycle arrest and apoptosis pathway.The LC50 Values of OEC-M1 and KB cells induced by AZ-1 compound were 0.72 and 1.02 mu M, respectively, which were much lower than that of normal fibroblast cells (SF with LC50 = 5.6 mu M) with more than 90% of normal fibroblasts surviving as compared to control at a concentration of AZ-1 as high as 2 mu M. It was interesting to note that the LC50 of monotype diaziridinylbenzoquinone compound, diaziquone (AZQ), was 50 mu M on OEC-M1 cells. Comparing the cytotoxicity of AZ-1 and AZQ on OEC-M1 cells, AZ-1 is approximately 70 times more potent than AZQ.By using Western blot, both G(2)/M phase cell cycle arresting protein, cyclin B, and anti-apoptotic protein, bel-2, were expressed in OEC-M1 cell when the concentrations or AZ-1 were increased from 0.125 to 0.5 mu M and then decreased from 1o 2 mu M of AZ-1 treatment as compared with control for 24 h. Both proteins were expressed most abundantly at 0.5 mu M AZ-1. However, the expression of bel-2 protein in OEC-M1 was significantly decreasing in a dose-dependent manner and was only about 50% protein level at 2 mu M AZ-1 for 48 h as compared with control. The cell survival check protein p53 increased from 1.72- to 2.8-fold and 1.36- to 2.16 fold at concentrations of AZ-1 from 0.125 to 2.0 mu M in it dose-dependently increasing manner on OEG-M1 as compared with control For 24 and 48 h treatments, respectively. The apoptotic-related phenomena were observed, which included apoptotic body formation and the enzyme activity change of caspase-3. The apoptotic bodies and caspase-3 activity of OEC-M1 were induced only at 2 mu M AZ-1 for a 24 h treatment, yet apoptotic body formation was observed at as low as 0.5 mu M AZ-1 and in a dose-dependently increasing manner for a 48 h treatment. The caspasc-3 activity was increased 20%, 26.8%, and 84.2%,, respectively, at 0.5, 1, and 2 mu M concentrations of AZ-1 for a 48 h treatment as compared with control. These results indicate that AZ-1 induced the cell death of OEG-M1 through the G(2)/M phase arrest of cell cycle and anti-apoptosis first and then apoptosis following a 48 h treatment. All of the pathway might be associated with bel-2 and p53 protein expression. We propose that the AZ-1 could be used its anti-oral cancer drug for future studies with animal models. (c) 2005 Elsevier Ltd. All rights reserved.

Anticancer Activity of Apaziquone in Oral Cancer Cells and Xenograft Model: Implications for Oral Cancer Therapy

Pro-Apoptotic Antitumoral Effect of Novel Acridine-Core Naphthoquinone Compounds against Oral Squamous Cell Carcinoma

A Novel Humanized Anti-Pd-1 Monoclonal Antibody Potentiates Therapy in Oral Squamous Cell Carcinoma.

Elucidating the Anticancer Mechanisms of Cinnamoyl Sulfonamide Hydroxamate: Insights From DNA Content Analysis and Gene Expression Profiling in Squamous Cell Carcinoma

Anticancer Potential of Quercetin on Oral Squamous Cell Carcinoma: A Scoping Review and Molecular Docking

The Lethal Effect of Bis-Type Azridinylnaphthoquinone Derivative on Oral Cancer Cells (OEC-M1) Associated with Anti-Apoptotic Protein Bcl-2.

Andrographolide demonstrates anti-proliferative activity in oral cancer by promoting apoptosis, the programmed cell death process

Sz-685c, A Marine Anthraquinone, is A Potent Inducer of Apoptosis with Anticancer Activity by Suppression of the Akt/Foxo Pathway

Unveiling the Therapeutic Potential of Quinazolinone Derivatives in Cancer Treatment: A Comprehensive Exploration

The Curcumin Analog (PAC) Has Anti-Oral Cancer Properties Through Impairing Pro-Survival Signaling Pathways and Activating the Cell Death Processes Apoptosis and Autophagy

Exploration of pro-apoptotic effect of Thymoquinone on oral squamous cell carcinoma cells through PI3K/Akt signaling pathway

New Oxazolo[5,4- d]pyrimidines as Potential Anticancer Agents: Their Design, Synthesis, and In Vitro Biological Activity Research

Anticancer effect and apoptosis induction by azaflavanone derivative in human prostate cancer cells

Prospects for Prostate Cancer Chemotherapy: Cytotoxic Evaluation and Mechanistic Insights of Quinolinequinones with ADME/PK Profile

A novel quinazoline derivative exhibits potent anticancer cytotoxicity via apoptosis and inhibition of angiogenesis in DMBA-induced mammary gland carcinoma

Oroxylum indicum Stem Bark Extract Reduces Tumor Progression by Inhibiting the EGFR-PI3K-AKT Pathway in an In Vivo 4NQO-Induced Oral Cancer Model

Murrayanine Exerts Antiproliferative Effects on Human Oral Cancer Cells Through Inhibition of AKT/mTOR and Raf/MEK/ERK Signalling Pathways in Vitro and Inhibits Tumor Growth in Vivo.

In Vitro Anticancer Screening and Preliminary Mechanistic Study of A-Ring Substituted Anthraquinone Derivatives

Synthesis and SAR Studies of Novel 6,7,8-Substituted 4-Substituted Benzyloxyquinolin-2(1H)-one Derivatives for Anticancer Activity.

Antitumoral and Antiproliferative Potential of Synthetic Derivatives of Scorpion Peptide IsCT1 in an Oral Cavity Squamous Carcinoma Model

Design and Synthesis of Propargyloxy Functionalized Pyrazole‐based Aurones: Exploring Their Potent Anticancer Properties Against AGS and MCF‐7 Cell Lines